Who are we?
GBF Strategy was founded by Dr Gordon McKenzie, an Engineer who has spent the last 20 years putting innovation into practice in the UK and internationally, especially in Germany and the USA. Gordon specialises in Imaging and AI Strategy and commercialisation. You can download Gordon's current CV here, or read on for more in-depth information.
Dr Daniel Woods joined GBF in 2019, having previously worked with Gordon at Michelson Diagnostics. Daniel is a Physicist, an imaging and device specialist who combines business acumen with a background in MRI, OCT and Optical Imaging.
Dr McKenzie with members of the ADVANCE group at the EADV Meeting in Amsterdam. Advance is an EU Framework 7 funded program to develop functional imaging for cancer detection.
Left to right: Prof. Giovanni Pellacani, Jon Holmes, Richard Whitehead, Prof. Gregor Jemec, Nikki Steadman, Dr. Gordon McKenzie, Dr. Mette Mogensen, Dr. Martina Ulrich, Prof. Julia Welzel.
History
After completing his PhD in Medical Engineering at the University of Warwick, Gordon worked as a Sales Applications Engineer at Sira Technology Ltd, offering research and development consultancy to companies requiring specialist opto-electronic services in the biomedical field. He also worked as a Smart Optics Technology Translator, helping other companies build collaborations and access appropriate support and funding
After several years, Gordon co-founded Michelson Diagnostics with four colleagues, developing innovative laser-scanning based imaging to improve clinical cancer care. This has given him a very wide range of hands-on skills relevant to early, innovative, growing companies. Daniel joined the Michelson team in 2011, acting as a business development manager, and working directly with clinical end users to guide the development and adoption of OCT in Dermatology throughout Europe.
After leaving Michelson Gordon set up GBF Strategy Ltd, offering business and clinical support services to companies and individuals who want to make a difference and grow their business. Gordon and Dan have real world experience of entrepreneurship and fundraising (£13.8M raised in equity finance), IP strategy development (a mixture of internal and licensed IP), technology development (brought four medical imaging devices to market in the EU, US and Australia), market development (UK, Germany and USA), outsourcing, and extensive international experience of collaboration with academia.
Depending on your needs, GBF has an extensive network of contacts to draw upon, including in Sales and Marketing, IP, Regulatory Affairs, Software, Statistics and Manufacturing. We have a particularly strong team in the Medical Device market development arena, with colleagues in sales, marketing and market strategy.